The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global varicose vein treatment market reached a value of US$ 388.74 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 551.75 Million by 2027, exhibiting a CAGR of 5.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Varicose vein treatment comprises self-care measures, compression stockings, and surgeries, such as sclerotherapy, laser treatment, catheter-based radiofrequency, high ligation and vein stripping, and ambulatory phlebectomy. It assists in treating twisted and enlarged veins that are close to the surface of the skin. It also helps reduce ache or heavy feeling in the legs, worsened pain after sitting or standing for a long time, itching around one or more of the veins, changes in skin color around varicose veins, and burning, throbbing, muscle cramping and swelling in the lower legs. As a result, it finds applications in hospitals, clinics, and ambulatory centers worldwide.
Presently, the rising prevalence of varicose vein problems among individuals, along with the growing geriatric population, represents one of the key factors driving the market across the globe. Moreover, there is an increase in the advancement of varicose vein treatment devices. This, coupled with the burgeoning healthcare industry, is propelling the growth of the market. In addition, the growing adoption of minimally invasive treatment procedures due to less postoperative pain, fewer operative and major postoperative complications, shortened hospital stay, and faster recovery times is positively influencing the market around the world. Besides this, the rising awareness among individuals about the treatment is offering lucrative growth opportunities to industry investors. Apart from this, key market players are extensively investing in research and development (R&D) activities to introduce advanced equipment, such as varithena and VenaSeal closure systems. In line with this, the increasing obesity among individuals due to changing lifestyles and lack of exercise is catalyzing the demand for varicose vein treatment. Other growth-inducing factors are technological advancements, prolonged standing hours at work, and excessive smoking.
IMARC Group provides an analysis of the key trends in each sub-segment of the global varicose vein treatment market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, procedure and end user.
Breakup by Product:
Breakup by Procedure:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Procedure, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at